Milford, MA 12/11/08—Waters has lowered its revenue and non-GAAP EPS forecast for the fourth quarter as a result of weaker than expected instrument orders and deteriorating economic conditions. The company now expects fourth-quarter sales to decline 4%–6% to $410–$420 million, including negative currency effects of approximately 4%. Previous guidance was approximately $454 million in sales, […]
Salt Lake City, Utah 12/8/08—Brigham Young University (BYU) and MS company Torion Technologies have filed suit against Hitachi High-Technologies America in the US District Court for the District of Utah, alleging infringement of US Patent No. 7,060,987, entitled “Electron Ionization Source for Orthogonal Acceleration Time-of-flight Mass Spectrometry.” BYU granted Torion an exclusive license to the […]
One of the more exciting developments in technology for life science research has been the adoption of medical imaging technologies for use with research animals. The ability to image animals in vivo not only reduces the need to sacrifice animals, but also enhances the information obtained from animal studies by allowing a researcher to follow […]
The FDA will continue to allow off-label use of the antibiotic cephalosporin in animals raised for food, including cows, chickens and pigs. In July, the FDA announced that it would crack down on the use of off-label antibiotics in animals used for food. The American Medical Association is among the groups critical of the overuse […]
Company Announcements Pall acquired GeneSystems, a provider of microbiological detection systems for process monitoring, in September. Invitrogen launched a patent-licensing program in September. New England Biolabs, QIAGEN GmbH and Kirkegaard & Perry Laboratories licensed technology covering the random prime amplification of nucleic acids. Takara Bio granted Promega a license to make, use and sell LA-PCR–related […]
Approved in November, the 2009 budget for Germany’s Federal Ministry of Education and Research (BMBF) increased 9.1% to €10.204 billion ($12.984 billion), or 2.9% of GDP. Funding for projects rose 15% to €3.5 billion. Project areas of focus include biotechnology and biomedical research. In total, funding for the life sciences increased 7.5% to €430 million. […]
The latest figures from IMS Health show that worldwide sales for generic drugs increased just 3.6% to $78 billion for the twelve months ending in September, compared to 11.4% growth for the same period last year. The decline is attributed to price competition. In the US, the world’s largest generics market, where generics make up […]
Milford, MA 12/5/08—Waters has purchased the net assets of Analytical Products Group (APG), a proficiency testing and quality-assurance services company, for an undisclosed amount. Waters will merge APG with its Environmental Resource Associates operations. APG has annual revenues of approximately $4 million. The acquisition is expected to be neutral to Waters’s 2009 earnings.
New York, NY 12/9/08—At its annual investors meeting, Agilent Technologies announced its outlook for fiscal 2009, which began November 1. In providing its expectations for the year, the company has modeled revenue from its Bio-Analytical Measurement (BAM) business to be flat at $2.2 billion, down from 17% growth in fiscal 2008. Regarding BAM, CEO and […]
The Chinese government has allocated CNY 6.6 billion ($880 billion) to drug discovery and development. The program will select Chinese companies, universities and research institutes to develop drugs for 10 disease areas (malignant tumors, heart disease, cardiovascular systems ailments, nervous system diseases, diabetes, psychosis, autoimmune problems, drug resistant infections, viral infectious diseases and tuberculosis). The […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
